Search
Now showing items 51-60 of 234
Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
(2021-04-23)
Background: In response to the COVID-19-pandemic, a lockdown was established in the middle of March 2020 by the German Federal Government resulting in drastic reduction of private and professional traveling in and out of ...
The e-psychonaut drugs’ psychopharmacology
(2021-04-01)
The focus here was on the pharmacological and clinical pharmacological issues pertaining to the vast range of drugs (e.g. synthetic cannabimimetics, synthetic opioids, novel stimulants, novel psychedelics, PCP/ketamine-like ...
Treatment of kratom use disorder with a classical tricyclic antidepressant: A case report and review
(2021-03-31)
Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe ...
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review
(2021-03-10)
Abstract: Introduction: Cognitive enhancers (CEs), also known as ‘smart drugs,’ ‘study aids’ or ‘nootropics’ are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university ...
Opioid painkillers' dependence in a sample of elderly medical inpatients
(2021-02-16)
BACKGROUND: Over the past few years there has been a growing concern towards prescription opioid misuse/dependence in the elderly. Thus, our study aimed at investigating the prevalence of previous and current prescribing ...
Identifying new/emerging psychoactive substances at the time of COVID-19; a web-based approach
(2021-02-09)
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, ...
The benzydamine experience: A systematic review of Benzydamine abuse
(2021-01-13)
Background: Both prescription and over-the-counter (OTC) drugs recently emerged among novel psychoactive substances (NPS) being reported as ingested for recreational purposes. Among them, benzydamine (BZY), normally ...
Beyond the Purple Drank. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports.
(2021-01-10)
Background: Promethazine is a medicinal product, available on its own or in combination with other ingredients including dextromethorphan, paracetamol, and/or expectorants. Anecdotal reports have however indicated that ...
Prescription drugs misuse in “clubbers” and disco goers in Ibiza
(2020-12-15)
Background: Prescription drugs misuse and its related risks are considered a worldwide public health issue. Current trends show that the extent of such phenomenon may not be limited to subjects with psychiatric disorders, ...
Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?
(2020-12-03)
Background: For cannabis-dependent subjects, the relationship between cannabis withdrawal syndrome (CWS) severity and the urine cannabinoid concentrations are unclear; we investigated this using a commercial point-of-care ...